MY176056A - Ophthalmic compositions and methods for treating eyes - Google Patents

Ophthalmic compositions and methods for treating eyes

Info

Publication number
MY176056A
MY176056A MYPI2010005691A MYPI2010005691A MY176056A MY 176056 A MY176056 A MY 176056A MY PI2010005691 A MYPI2010005691 A MY PI2010005691A MY PI2010005691 A MYPI2010005691 A MY PI2010005691A MY 176056 A MY176056 A MY 176056A
Authority
MY
Malaysia
Prior art keywords
eyes
ophthalmic compositions
methods
treating eyes
treating
Prior art date
Application number
MYPI2010005691A
Inventor
G Vehige Joseph
A Simmons Peter
Chang-Lin Joan-En
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Priority to MYPI2010005691A priority Critical patent/MY176056A/en
Publication of MY176056A publication Critical patent/MY176056A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
MYPI2010005691A 2010-11-30 2010-11-30 Ophthalmic compositions and methods for treating eyes MY176056A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2010005691A MY176056A (en) 2010-11-30 2010-11-30 Ophthalmic compositions and methods for treating eyes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2010005691A MY176056A (en) 2010-11-30 2010-11-30 Ophthalmic compositions and methods for treating eyes

Publications (1)

Publication Number Publication Date
MY176056A true MY176056A (en) 2020-07-23

Family

ID=79169817

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010005691A MY176056A (en) 2010-11-30 2010-11-30 Ophthalmic compositions and methods for treating eyes

Country Status (1)

Country Link
MY (1) MY176056A (en)

Similar Documents

Publication Publication Date Title
TW200631605A (en) Ophthalmic compositions and methods for treating eyes
MY169328A (en) Compositions for the treatment of dry eye
MX2011013060A (en) Ophthalmic formulations, methods of manufacture, and methods of using same.
MY171920A (en) Prevention and treatment of ocular conditions
MA39767A (en) Aqueous ophthalmic solution and method for treating dry eye syndrome
MX2009012645A (en) Formulations and methods for treating dry eye.
MX2023003124A (en) Ophthalmic pharmaceutical compositions and uses relating thereto.
MX2019003364A (en) Ophthalmic compositions comprising ciclosporin.
WO2014015274A8 (en) Methods for tissue passivation
WO2013180834A3 (en) Compositions and methods of inhibiting masp-1, masp-2 and/or masp-3 for treatment of paroxysmal nocturnal hemoglobinuria
PH12017500922A1 (en) Stabilized omega-3 ophthalmic compositions
WO2012061045A3 (en) Methods and compositions for preserving retinal ganglion cells
WO2012080497A3 (en) Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
PH12021550621A1 (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
PH12017500098A1 (en) Suspension compositions of cyclosporin a for subconjunctival and periocular injection
PH12017500615B1 (en) Ophthalmic composition comprising cyclosporine and trehalose
WO2016127123A3 (en) Compounds and methods for preventing or treating sensory hair cell death
WO2013189606A3 (en) Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
WO2013046059A3 (en) Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
WO2014116015A3 (en) Composition for preventing alzheimer's disease, containing purple bamboo salt, and method for preparing purple bamboo salt
MX350201B (en) Ophthalmic compositions with alkoxylated natural waxes.
WO2009126695A3 (en) Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
WO2013138338A3 (en) Methods for treating tissue damage associated with ischemia with apoliporotein d
MY176056A (en) Ophthalmic compositions and methods for treating eyes
TW201613596A (en) Ophthalmic suspension preparation